.svg)
BLOG
The Latest on SolidIO
Solid IO Awarded European Partnership for Personalized Medicine Grant
This competitive EU funding instrument accelerates Solid IO’s progress and strengthens it's position in the personalized medicine space.
Solid IO Awarded European Partnership for Personalized Medicine Grant
This competitive EU funding instrument accelerates Solid IO’s progress and strengthens it's position in the personalized medicine space.
Solid IO Joins Leading Nordic Accelerator for Female Tech Founders
Solid IO's CEO and CSO have been selected to join the Tech Nordic Advocates International Accelerator Programme, a highly competitive six-month growth programme for women-led tech companies building for global impact.
Solid IO Awarded €400 000 R&D Grant From Business Finland
This significant early-stage public funding strengthens our position as a developer of next-generation precision oncology diagnostics and enables us to accelerate our path toward market entry.
Strategic Funding: More than just capital
Solid IO closed its first equity funding round immediately after spinning out from the University of Helsinki.
Solid IO Raises € 800 000 to Eliminate the Guesswork in Cancer Care
The Funding will Support Next-Generation Tumor Modeling for Precision Oncology & Immunotherapy Advancements
Shape the future of cancer care
Join SolidIO in transforming cancer care with groundbreaking organ-on-chip technology. We’re calling on researchers, clinicians, and investors to partner with us in advancing precision medicine, accelerating innovation, and expanding global access to personalized oncology. Together, we can bring clarity and better outcomes to cancer care worldwide.